Daily Cosmetic Research Analysis
Three studies advance cosmetic and dermatologic research from complementary angles: a cohort analysis shows poor agreement between physician-rated and software-assessed breast cosmesis after radiotherapy; a scoping review highlights multifactorial barriers to photoprotection among Skin of Color populations; and an in vivo multi-omics investigation supports Sapindus saponins as a multi-target anti-acne candidate.
Summary
Three studies advance cosmetic and dermatologic research from complementary angles: a cohort analysis shows poor agreement between physician-rated and software-assessed breast cosmesis after radiotherapy; a scoping review highlights multifactorial barriers to photoprotection among Skin of Color populations; and an in vivo multi-omics investigation supports Sapindus saponins as a multi-target anti-acne candidate.
Research Themes
- Objective vs subjective assessment of cosmetic outcomes after cancer therapy
- Equity-focused photoprotection strategies in Skin of Color
- Natural product-based, multi-target anti-acne therapeutics with multi-omics
Selected Articles
1. Physician and Software Assessed Cosmetic Outcomes Following Whole Breast or Partial Breast Radiation Therapy for Breast Cancer.
Breast cosmesis after both whole-breast and partial-breast irradiation was generally favorable, but agreement between physician-rated Harvard scores and BCCT.core software was poor. BCCT.core detected greater longitudinal cosmetic decline, and clinical radiotherapy parameters had little association with long-term cosmesis except for higher scores with oncoplastic surgery.
Impact: Establishes a critical discrepancy between subjective and objective cosmetic assessment after breast radiotherapy, informing quality measurement and patient counseling. Highlights surgery as a dominant determinant of long-term cosmesis.
Clinical Implications: Incorporate objective tools like BCCT.core alongside physician assessment to monitor cosmesis; counsel patients that objective measures may reveal greater decline over time; prioritize surgical planning for cosmetic outcomes rather than expecting differences between WBI and PBI.
Key Findings
- Physician-rated excellent/good cosmesis at follow-up: WBI 91%, PBI 86.1%; BCCT.core: WBI 68.4%, PBI 72.2%
- Very low agreement between physician and software (κ=0.057 WBI; κ=0.012 PBI)
- BCCT.core detected a 27.3% decline over time for WBI, versus <15% decline by physician rating
- Positioning, boost, fractionation, and regional nodal irradiation were not associated with long-term cosmesis; oncoplastic surgery was associated with better scores
Methodological Strengths
- Dual assessment using standardized photographs with BCCT.core and physician-rated Harvard scale
- Inclusion of both WBI and PBI cohorts for comparative analysis
Limitations
- Observational, non-randomized design with modest sample size (especially PBI n=36)
- Lack of patient-reported outcomes and unspecified follow-up duration
Future Directions: Integrate patient-reported outcomes and longer follow-up; validate automated tools across diverse populations; assess combined surgical-radiation planning strategies to optimize cosmesis.
AIM: This study aims to compare the cosmetic outcomes in early-stage breast cancer patients treated with whole breast irradiation (WBI) or partial-breast irradiation (PBI), using both subjective and objective tools, to assess clinical factors contributing to cosmesis scores, and to compare radiation toxicity outcomes. METHODS: Breast cosmesis was scored by using the physician-rated Harvard cosmesis scale at the time of consultation and at each follow-up visit and objectively using the BCCT.core software on standardized photographs. RESULTS: Ninety-nine patients received WBI, and thirty-six received PBI. 91% of patients treated with WBI and 86.1% with PBI scored excellent/good by physician ratings at follow-up vs. 68.4% and 72.2 % by BCCT.core software. Agreement between both tools was low (κ = 0.057 for WBI patients and κ = 0.012 for PBI patients). There was less than a 15% decline in physician-rated cosmetic scores for either WBI or PBI patients, but a 27.3% decline for WBI patients by BCCT.core software scoring. There was no association of prone vs. supine position, tumor bed boost, fractionation scheme, or addition of regional nodal irradiation with long-term cosmesis scores determined by either assessment tool, except for oncoplastic surgery which was associated with a higher score. CONCLUSIONS: Breast cosmesis scores after either WBI or PBI are favorable; however, the agreement between physician rating and the BCCT.core software is poor. The BCCT.core software was more likely to indicate a decline in cosmetic results over time. Surgical outcomes may be the most impactful clinical factor in predicting long-term breast cosmesis.
2. In vivo bacterial infection acne treatment of Sapindus saponins: Skin microbiota, network pharmacology, and transcriptomic analysis.
Sapindus saponins reduced acne lesion severity in a rabbit ear model without acute skin or eye irritation below 50 mg/mL, decreased inflammatory mediators and dihydrotestosterone/leukotriene, and modulated skin microbiota. Multi-omics integration identified convergent targets (e.g., TNF, VDR, AR, PTGS2, PPARG, NR3C1) and implicated MAPK and cytokine pathways.
Impact: Provides in vivo efficacy and mechanistic targets for a natural, multi-target anti-acne candidate, bridging ethnopharmacology with modern multi-omics and microbiome analyses.
Clinical Implications: Supports development of multi-target topical agents that may reduce reliance on antibiotics for acne; warrants dose-ranging, formulation, and human clinical trials to confirm safety and efficacy.
Key Findings
- No acute or continuous skin/eye irritation below 50 mg/mL in New Zealand rabbits
- Significant reduction in rabbit ear acne lesion severity after 14 days of SMSF treatment
- Decreased pro-inflammatory factors, dihydrotestosterone, and leukotriene; modulation of skin microbiota structure
- Network pharmacology predicted 79 anti-acne targets; transcriptomics identified 2084 DEGs with 6 overlapping targets (TNF, VDR, AR, PTGS2, PPARG, NR3C1)
- Pathways implicated include protein synthesis maintenance, cytokine regulation, and MAPK signaling
Methodological Strengths
- Combined in vivo efficacy with toxicity assessment
- Integrated network pharmacology, transcriptomics, and microbiome profiling
- Multiple mechanistic endpoints (hormonal, inflammatory, microbial)
Limitations
- Preclinical animal model limits generalizability to humans
- Sample size and detailed dosing schema not specified in abstract
- No long-term safety or relapse data; composition of SMSF not fully characterized for clinical translation
Future Directions: Conduct dose-ranging and formulation studies, followed by randomized clinical trials; isolate active constituents and validate target engagement in human skin; assess antibiotic-sparing potential.
ETHNOPHARMACOLOGICAL RELEVANCE: Sapindus mukorossi has been traditionally used in China for skin whitening and acne treatment. Previous studies have confirmed the antibacterial activity of Sapindus saponins against Cutibacterium acnes, which is reportedly the primary factor causing inflamed lesions in acne vulgaris. However, the anti-acne activity in vivo and related cellular targets of Sapindus saponins are still unknown. AIM OF THE STUDY: This study aimed to investigate the anti-acne effects in vivo and the action mechanism of Sapindus mukorossi saponins fraction (SMSF) by the strategy of network pharmacology, transcriptomic analysis, and microbiome integration. MATERIALS AND METHODS: The network pharmacology analysis was used to evaluate the cellular targets of SMSF treatment on acne. The transcriptome analysis was utilized to identify the differentially expressed genes (DEGs), and the 16S rDNA sequencing was employed to analyze the composition of skin microbiota. RESULTS: SMSF was proven to have no acute, continuous skin or eye irritation in New Zealand rabbits when the concentration was below 50 mg/mL. SMSF could greatly reduce the lesion degree of rabbit ear acne and significantly decrease the content of pro-inflammatory factors in the rabbit ear tissue and serum after treatment for 14 days. The contents of dihydrotestosterone and leukotriene were significantly decreased, and the structure of bacterial microbiota was regulated. The network pharmacology analysis showed that the main 79 anti-acne targets of SMSF such as tumor necrosis factor (TNF) and interleukin 10. The transcriptomic analysis confirmed that there were 2084 DEGs between the SMSF-treated group and the model group, of which 870 were up-regulated and 1214 were down-regulated. Correlation analysis between the DEGs and the anti-acne targets predicted by network pharmacology showed that there were 6 overlapping targets, including TNF, vitamin D receptor, androgen receptor, prostaglandin endoperoxide synthase 2, peroxisome proliferator activated receptor gamma, and nuclear receptor subfamily 3, group C, member 1. Moreover, SMSF achieved anti-acne activities by maintaining normal cellular protein synthesis, regulating cytokine production as well as regulating cancer-related genes and the mitogen-activated protein kinase signaling pathway. CONCLUSION: SMSF exerted anti-acne activities via multiple targets and signaling pathways. This study provided a theoretical basis for the utilization of Sapindus saponins in the fields of medicine and cosmetics, and supplied a guiding significance for the development of natural anti-acne drugs.
3. Photoprotection in Skin of Color: A Scoping Review of Barriers, Behaviors, and Pediatric Considerations.
This scoping review finds that Skin of Color populations benefit from photoprotection but engage less in sun-safe behaviors due to cultural, educational, and societal factors and misconceptions about innate protection. It advocates culturally tailored education, community engagement, and healthcare integration, with emphasis on pediatric considerations.
Impact: Addresses health equity by synthesizing barriers to photoprotection in Skin of Color and outlines actionable strategies to improve sun-safe behaviors, particularly relevant for pediatric dermatology.
Clinical Implications: Implement culturally tailored counseling on photoprotection during pediatric and dermatology visits; correct misconceptions about innate protection; increase representation of Skin of Color in educational materials and research.
Key Findings
- Skin of Color populations can sunburn and develop skin cancer, often presenting at advanced stages with higher morbidity and melanoma mortality
- Photoprotection benefits SOC, yet knowledge and participation in sun-protective behaviors are lower
- Barriers include cultural values, family dynamics, gender, education, and beauty norms; misconceptions about innate protection contribute
- Strategies include culturally relevant education, community engagement, healthcare integration, and increased SOC representation in research
Methodological Strengths
- Structured search across EMBASE, MEDLINE, and PubMed over a defined 5-year window
- Focus on original human studies and explicit exclusion criteria
Limitations
- Scoping review methodology without meta-analysis limits quantitative synthesis
- English-only inclusion and recent time window may introduce selection bias
- Heterogeneity in included study designs and outcomes
Future Directions: Develop and test culturally tailored photoprotection interventions in randomized or pragmatic trials, with pediatric-focused components and community partnerships; standardize outcomes for sun-protective behaviors.
Individuals with skin of color (SOC) can sunburn and develop skin cancer, often presenting at advanced stages with higher morbidity and melanoma-related mortality. However, patient education on photoprotection for SOC populations remains limited. This scoping review investigated the benefits of photoprotection and the factors influencing sun protective behaviors in SOC populations. EMBASE, MEDLINE, and PubMed were searched from January 1st, 2018 to December 31st, 2022, using the overarching terms of "SOC," "skin cancer," and "photoprotection." Original, English-language studies were included, while non-human and incomplete studies were excluded. The review found that while photoprotection benefits SOC populations, individuals within these groups exhibit lower knowledge of and participation in sun-protective behaviors. This gap is influenced by a complex interplay of factors, including cultural values, family dynamics, gender, education, and societal norms surrounding beauty. Misconceptions about innate sun protection contribute to this gap. To address this, culturally relevant education, community engagement, healthcare integration, and increased representation of SOC in dermatological research are essential to improving sun-safe habits in these communities.